Quick Takeaways
- NSV Investments I, L.P. filed SCHEDULE 13D/A for Ventyx Biosciences, Inc. Common stock, par value $0.0001 per share (VTYX).
- Disclosed ownership: 7.6%.
- Date of event: 10 Mar 2025.
NSV Investments I, L.P. - 10 Mar 2025 SCHEDULE 13D/A Report for Ventyx Biosciences, Inc. Common stock, par value $0.0001 per share (VTYX)
- Filing Manager
- NSV Investments I, L.P.
- Reporting Manager
- Somasundaram Subramaniam
- Symbol
- VTYX
- Shares outstanding
- 71,387,171 shares
- Disclosed Ownership
- 5,425,425 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 12 Mar 2025, 16:05:10 UTC
- Date of event
- 10 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"NSV Investments I, L.P. disclosed 7.6% ownership in Ventyx Biosciences, Inc. Common stock, par value $0.0001 per share (VTYX) on 10 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Mar 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NSV Investments I, L.P. | 4.4% | 3,143,114 | 0 | 3,143,114 | /s/ Tom Lavin | Tom Lavin/Partner | 0001889184 |
| NSV Partners III, L.P. | 6.4% | 4,524,720 | 0 | 4,524,720 | /s/ Tom Lavin | Tom Lavin/Partner | 0001309180 |
| NSV Partners III GP, LLC | 6.4% | 4,524,720 | 0 | 4,524,720 | /s/ Tom Lavin | Tom Lavin/Partner | 0001889601 |
| Somasundaram Subramaniam | 7.6% | 5,425,425 | 57,762 | 5,367,663 | /s/ Somasundaram Subramaniam | Somasundaram Subramaniam |